Six changes in IMiD‐resistant HMCLs were consistent with those identified in RR samples from MM patients, including upregulation of PRR11, HN1, RFC3, PSMB2, PSMD14, and downregulation of SKA2. Here, PSMB2 is linked to Miyoshi myopathy.